APA (7th ed.) Citation

S, G., JM, T., Y, R., M, O., FN, R., V, B., . . . GW, S. (2015). A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model. Vaccine, 33(38), 4798. https://doi.org/10.1016/j.vaccine.2015.07.081

Chicago Style (17th ed.) Citation

S, Gupta, Termini JM, Rivas Y, Otero M, Raffa FN, Bhat V, Farooq A, and Stone GW. "A Multi-trimeric Fusion of CD40L and Gp100 Tumor Antigen Activates Dendritic Cells and Enhances Survival in a B16-F10 Melanoma DNA Vaccine Model." Vaccine 33, no. 38 (2015): 4798. https://doi.org/10.1016/j.vaccine.2015.07.081.

MLA (9th ed.) Citation

S, Gupta, et al. "A Multi-trimeric Fusion of CD40L and Gp100 Tumor Antigen Activates Dendritic Cells and Enhances Survival in a B16-F10 Melanoma DNA Vaccine Model." Vaccine, vol. 33, no. 38, 2015, p. 4798, https://doi.org/10.1016/j.vaccine.2015.07.081.